Open original FDA record ↗Recall record
- FDA identifier
- Z-0266-2027
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Oct 22, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Wrong lead or percutaneous extension selected. Use of an incompatible lead or percutaneous extension will prevent the system from working as intended and may result in delay of surgery or need for surgical replacement of the product.
Source facts
- Action
- Firm began distributing Urgent Medical Device Correction letters to consignees via email or mail starting 9/15/26. The letter included recommendations for system and patient management: - Verify InterStim product names and model numbers are compatible prior to the procedure. - Review letter for a summary of compatible product information. - Consult the System Overview and Compatibility Insert at www.manuals.medtronic.com for additional product compatibility information. - Ensure a system integrity check is performed prior to completing the implant procedure per the applicable product manual. - Contact your Medtronic Representative or Technical Services for any additional support as needed.
- Initiated
- 2026-09-08
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide and territory of Puerto Rico. The countries of Brazil, Colombia, Chile, Canada, Japan, New Zealand, Australia, United Kingdom, Switzerland, Sweden, Spain, Portugal, Italy, Israel, Germany, France, Finland, Canary Islands, Belgium, Austria, Norway, Northern Ireland, Netherlands, Iceland, Denmark, South Africa, Turkey, Slovakia, Saudi Arabia, Poland, Hungary, United Arab Emirates (UAE), Kuwait, Greece.
- Recall number
- Z-0266-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222961
- FDA classified
- 2026-10-22
- Recall event number
- 99949